國家衛生研究院 NHRI:Item 3990099045/11637
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12189/12972 (94%)
造訪人次 : 967015      線上人數 : 792
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/11637


    題名: CD44 promotes migration ability of docetaxel-resistant prostate cancer cells via induction of Hippo-Yap signaling
    作者: Lai, CJ;Chuu, CP;Wang, HD
    貢獻者: Institute of Cellular and Systems Medicine
    摘要: Docetaxel-based chemotherapy confers higher five-year survival rate for patients with castration-resistant prostate cancer (CRPC). However, docetaxel-resistant prostate cancers are more malignant related to poor prognosis. We determine the cause of the aggressive phenotype of docetaxel-resistant prostate cancer (PCa). In our study, the docetaxel-resistant CRPC- PC/DX25 cells exhibit higher mobility and express more endogenous CD44. CD44 is a multifunctional protein involved in regulation of drug resistance and cell migration. CD44 has been reported to function as upstream regulator of Yes-associated protein (YAP), a major mediator in Hippo-pathway which is involved in human tumorigenesis. Knockdown of CD44 reduces protein expression of YAP but increases protein level of phospho-YAP S127. Phosphorylation of S127 on YAP suppresses the oncogenic activity of YAP as well as decreases protein expression of CTGF and CYR61, the downstream genes of YAP. CTGF and CYR61 are related to cell migration, cell invasion, and cell adhesion. In conclusion, CD44/YAP pathway may be a potential therapeutic target for docetaxel-resistant CRPCs.
    日期: 2018-12
    關聯: Cancer Science. 2018 Dec;109(Suppl. 2):990.
    Link to: https://doi.org/10.1111/cas.13904
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1347-9032&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000453773604366
    顯示於類別:[褚志斌] 會議論文/會議摘要

    文件中的檔案:

    檔案 大小格式瀏覽次數
    ISI000453773604366.pdf35KbAdobe PDF255檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋